Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 127 #1
CompanyPorter Bancorp Inc.
IndustryRegional - Southeast Banks
Market Cap22.84MEPS (ttm)1.58
P/E0.75EPS this Y648.30%
Forward P/E-EPS next Y-
PEG0.75EPS past 5Y9.70%
P/S0.59EPS next 5Y1.00%
P/B0.67EPS Q/Q125.00%
Dividend-Sales Q/Q-7.10%
Insider Own15.30%Inst Own22.20%
Insider Trans0.82%Inst Trans120.03%
Short Float0.34%EarningsApr 30/a
Analyst Recom3.00Target Price1.50
Avg Volume8.35K52W Range0.46 - 1.25
May-20-15 01:04PMPORTER BANCORP, INC. Financials
May-15-15 09:00AMLatest Buzz in the Financial Sector: Complementary Research on Porter Bancorp, Planet Payment, Bankwell Financial, Impac Mortgage and QCR Holdings PR Newswire
May-13-15 08:11PM10-Q for Porter Bancorp, Inc. at Company Spotlight
May-11-15 04:37PMPORTER BANCORP, INC. Files SEC form 10-Q, Quarterly Report
Apr-30-15 04:12PMPORTER BANCORP, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
Apr-30-15 04:05PMPorter Bancorp, Inc. Reports $409,000 First Quarter 2015 Net Income Business Wire
Apr-28-15 08:14PM10-K for Porter Bancorp, Inc. at Company Spotlight
Apr-28-15 05:15PMPorter Bank has a plan to boost its stock price at
Mar-30-15 04:23PMPORTER BANCORP, INC. Files SEC form 10-K, Annual Report
CompanyPrima Biomed Ltd.
Market Cap139.75MEPS (ttm)-0.27
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S121.52EPS next 5Y-
P/B7.82EPS Q/Q-
Dividend-Sales Q/Q-32.90%
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float0.00%Earnings-
Analyst Recom-Target Price-
Avg Volume1.85M52W Range0.42 - 6.48
May-22-15 09:35AMCan These Stocks Provide Investors with Further Gains? Accesswire
May-20-15 08:19PMPrima Biomed (PBMD) Stock Skyrockets 270 Percent on Positive Drug Trial - Stocks in the News
May-20-15 01:19PMPrima Biomed (PBMD) Stock Nearly Quardruples in Value on Positive Clinical Study Results at TheStreet
May-19-15 10:19AMCVac Shows Clear Trend for Overall Survival Benefit in Second Remission Ovarian Cancer in Phase II Study Marketwired
May-19-15 02:20AMCancer vaccine maker seeks partner Other
May-18-15 09:03PMPrima Biomed shares shoot up Other
May-14-15 06:45AMPrima BioMed Announces A$15 Million Investment From US Healthcare Investor Ridgeback Marketwired
May-14-15 12:18AMUS hedge fund's $15m injection for Prima Other
CompanyChina Information Technology, Inc.
IndustryApplication Software
Market Cap158.12MEPS (ttm)-2.48
P/E-EPS this Y-31.30%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-45.20%
P/S2.30EPS next 5Y23.00%
P/B3.08EPS Q/Q100.00%
Dividend-Sales Q/Q9.50%
Insider Own68.09%Inst Own1.10%
Insider Trans0.00%Inst Trans-11.25%
Short Float0.53%EarningsMar 31
Analyst Recom3.00Target Price9.00
Avg Volume81.82K52W Range2.91 - 7.35
May-21-15 09:22AM9:22 am China Information Tech enters into a securities purchase agreement with certain institutional investors for the sale of 2,102,484 ordinary shares in a registered offering at the price of $6.44/share
May-21-15 08:30AMChina Information Technology, Inc. Announces Entry Into Agreement for $13.54 Million Registered Direct Offering of Ordinary Shares and Warrants PR Newswire
May-15-15 06:00AMCNIT Expands New Media Offerings in Wudang District of Guiyang City PR Newswire
May-12-15 06:00AMCNIT Entered Into Strategic Agreement with of Shenzhen Press Group PR Newswire
May-05-15 06:00AMCNIT Entered Into Strategic Agreement with the $1.6 Billion Shenzhen Capital Group PR Newswire
TickerISR [AMEX]
CompanyIsoRay, Inc.
IndustryMedical Instruments & Supplies
Market Cap110.84MEPS (ttm)-0.11
P/E-EPS this Y-45.50%
Forward P/E28.86EPS next Y275.00%
PEG-EPS past 5Y9.90%
P/S26.39EPS next 5Y-
P/B4.93EPS Q/Q0.00%
Dividend-Sales Q/Q0.00%
Insider Own0.70%Inst Own7.00%
Insider Trans4.54%Inst Trans2.21%
Short Float8.03%EarningsMay 18
Analyst Recom2.00Target Price5.00
Avg Volume2.38M52W Range1.22 - 3.79
May-21-15 10:00PMISORAY INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates IsoRay, Inc. for Possible Stock Fraud Business Wire
May-21-15 09:58PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of IsoRay, Inc. - ISR PR Newswire
May-21-15 07:22PMA New Exclusive Audio Interview With IsoRay, Inc. CEO Dwight Babcock Is Now Available at Corporate Media Straight Marketwired
May-21-15 04:55PMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Law Violations by the Board of IsoRay, Inc. Business Wire
May-21-15 03:38PMEQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against IsoRay, Inc. ISR Business Wire
May-21-15 11:36AMIsoRay Takes Liberties With Lung Cancer Study Results to Prop Up Stock Price at TheStreet
May-20-15 08:17AM8:17 am IsoRay reports that the survival rate at 5 years was 100% for Cesium-131 lung cancer treatment group, which included many high risk patients, and Cesium-131 added no noticeable side effects
May-20-15 08:15AMIsoRay's Cesium-131 Lung Cancer Treatment Reports 96% Success in Local Control and 100% Survival at 5 Years in High Risk Patients in Newly Published Report Marketwired
CompanyCellular Biomedicine Group Inc.
Market Cap342.43MEPS (ttm)-1.38
P/E-EPS this Y27.00%
Forward P/E-EPS next Y11.20%
PEG-EPS past 5Y-20.20%
P/S570.72EPS next 5Y-
P/B7.98EPS Q/Q-50.00%
Dividend-Sales Q/Q300.00%
Insider Own-Inst Own1.40%
Insider Trans-Inst Trans305.26%
Short Float3.07%EarningsMay 18
Analyst Recom1.00Target Price33.50
Avg Volume127.29K52W Range5.00 - 49.00
May-22-15 09:17AMCellular Biomedicine Group Announces Positive Phase I Results From CAR-T CD30 Immuno-Oncology Clinical Development Program GlobeNewswire
May-22-15 09:17AM9:17 am Cellular Biomedicine announces 'encouraging' clinical data from its Chimeric Antigen Receptor CD30-positive Hodgkin's lymphoma immuno-oncology clinical development program
May-20-15 11:28AMINVESTOR ALERT: Investigation of Cellular Biomedicine Group Inc. Announced by The Law Offices of Howard G. Smith Business Wire
May-18-15 04:46PMSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Cellular Biomedicine Group Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit CBMG GlobeNewswire
May-18-15 06:23AMCellular Biomedicine reports 1Q loss
May-18-15 06:10AMCellular Biomedicine Group Reports First Quarter 2015 Financial Results and Provides Business Highlights GlobeNewswire
May-15-15 12:20PMCELLULAR BIOMEDICINE GROUP, INC. Files SEC form 10-Q, Quarterly Report
May-15-15 10:45AMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Cellular Biomedicine Group Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of June 22, 2015 - CBMG PR Newswire
May-12-15 09:30AMCellular Biomedicine Group, Inc. Featured on Wide World of Stocks Television GlobeNewswire
CompanyProPhase Labs, Inc.
IndustryDrug Related Products
Market Cap21.73MEPS (ttm)-0.49
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-9.40%
P/S1.00EPS next 5Y-
P/B2.32EPS Q/Q-80.00%
Dividend-Sales Q/Q-4.80%
Insider Own19.20%Inst Own26.10%
Insider Trans7.41%Inst Trans-0.07%
Short Float0.19%EarningsFeb 12/b
Analyst Recom-Target Price15.55
Avg Volume23.67K52W Range1.21 - 2.02
May-15-15 08:09PM10-Q for ProPhase Labs, Inc. at Company Spotlight
May-13-15 04:31PMPROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
May-13-15 04:24PMPROPHASE LABS, INC. Files SEC form 10-Q, Quarterly Report
May-13-15 04:10PMProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2015 Marketwired
Apr-29-15 08:15PM10-K for ProPhase Labs, Inc. at Company Spotlight
Apr-17-15 04:22PMPROPHASE LABS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Apr-02-15 01:04PMPROPHASE LABS, INC. Financials
Mar-27-15 01:10PMPROPHASE LABS, INC. Files SEC form 10-K, Annual Report
Mar-26-15 06:04AMPROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
CompanyOncothyreon Inc
Market Cap256.77MEPS (ttm)-0.55
P/E-EPS this Y-3.20%
Forward P/E-EPS next Y-14.70%
PEG-EPS past 5Y3.40%
P/S-EPS next 5Y-
P/B2.32EPS Q/Q42.90%
Dividend-Sales Q/Q-
Insider Own0.10%Inst Own60.00%
Insider Trans389.49%Inst Trans10.40%
Short Float4.86%EarningsMay 11/a
Analyst Recom2.00Target Price3.50
Avg Volume1.78M52W Range1.41 - 3.60
May-22-15 06:01AMBiotech Stock Mailbag: ASCO Preview, CAR-T stocks, MannKind, Hate Mail! at TheStreet
May-19-15 01:04PMONCOTHYREON INC. Financials
May-19-15 08:35AMOncothyreon (ONTY) Looks Good: Stock Up 6.6% in Session - Tale of the Tape
May-19-15 08:32AMWhy Oncothyreon (ONTY) is Poised to Beat Earnings Estimates - Tale of the Tape
May-18-15 07:26AMWill Oncothyreon (ONTY) Continue to Surge Higher? - Tale of the Tape
May-14-15 04:55PMONCOTHYREON INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or By
May-14-15 03:08PMThe 5 Winners and Losers From ASCO Presentations at 24/7 Wall St.
May-13-15 08:11PM10-Q for Oncothyreon, Inc. at Company Spotlight
May-13-15 05:00PMJumpstart ASCO '15 With This Quick List of Hot Research Abstracts at TheStreet
CompanyAVEO Pharmaceuticals, Inc.
Market Cap122.74MEPS (ttm)-1.09
P/E-EPS this Y51.90%
Forward P/E-EPS next Y32.50%
PEG-EPS past 5Y48.30%
P/S40.91EPS next 5Y-
P/B7.96EPS Q/Q-75.00%
Dividend-Sales Q/Q-99.30%
Insider Own0.30%Inst Own30.90%
Insider Trans-9.36%Inst Trans6.21%
Short Float0.21%EarningsMay 07/b
Analyst Recom3.30Target Price3.00
Avg Volume3.02M52W Range0.61 - 3.50
May-22-15 09:35AMCan These Stocks Provide Investors with Further Gains? Accesswire
May-21-15 01:40PMHow to Evaluate a 50% Move in AVEO at 24/7 Wall St.
May-21-15 12:01PMWhat's Up With The Delayed Reaction In Aveo Pharmaceuticals?
May-20-15 07:02AM7:02 am AVEO Oncology announces final results from its TIVO-1 extension study, demonstrating the efficacy of tivozanib in a VEGF treatment refractory population.
May-20-15 07:00AMAVEO Oncology Announces Presentation of Final Results of Extension Study 902 and FDA Regulatory Feedback for Advancing Tivozanib in Renal Cell Carcinoma Business Wire
May-19-15 01:04PMAVEO PHARMACEUTICALS INC Financials
May-11-15 12:10PMOn the move: New hires and appointments in the local life sciences industry at
May-10-15 08:11PM10-Q for AVEO Pharmaceuticals, Inc. at Company Spotlight
May-07-15 08:00AMAVEO Pharmaceuticals' (AVEO) Q1 Loss Narrower than Expected - Tale of the Tape
CompanyRADA Electronic Industries Ltd.
IndustryElectronics Wholesale
Market Cap22.09MEPS (ttm)0.04
P/E61.50EPS this Y-30.40%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-33.80%
P/S0.95EPS next 5Y-
P/B6.00EPS Q/Q66.70%
Dividend-Sales Q/Q6.70%
Insider Own-Inst Own3.10%
Insider Trans-Inst Trans-2.11%
Short Float9.86%EarningsApr 29
Analyst Recom-Target Price-
Avg Volume860.81K52W Range1.30 - 6.29
May-22-15 09:35AMCan These Stocks Provide Investors with Further Gains? Accesswire
Apr-29-15 11:47AMRADA Electronic Industries Announces Filing of 2014 Annual Report GlobeNewswire
Apr-29-15 11:44AMRADA Electronic Industries Announces Full Year 2014 Results GlobeNewswire
Mar-31-15 12:13PMRADA Electronic Industries (RADA) Stock Is Up Today on DRS Technologies Agreement at TheStreet
Mar-31-15 10:30AMRADA Electronic Industries and DRS Technologies Team for the North American AESA Radar Market GlobeNewswire
Mar-23-15 10:39AMRADA Electronic Industries (RADA) Stock Spikes Today on Lockheed Martin Radar Deal at TheStreet
Mar-23-15 10:00AMRADA Radar Selected by Lockheed Martin for Laser Weapon Research Projects GlobeNewswire
CompanyeLong Inc.
IndustryInternet Software & Services
Market Cap693.22MEPS (ttm)-1.21
P/E-EPS this Y-56.40%
Forward P/E-EPS next Y86.60%
PEG-EPS past 5Y-62.70%
P/S3.96EPS next 5Y0.00%
P/B2.57EPS Q/Q-365.00%
Dividend-Sales Q/Q-5.70%
Insider Own15.00%Inst Own8.90%
Insider Trans0.00%Inst Trans-4.23%
Short Float0.99%EarningsApr 30/a
Analyst Recom2.80Target Price18.17
Avg Volume29.74K52W Range12.76 - 24.00
May-22-15 04:24AM4:24 am eLong: Expedia sells its majority stake in eLong
May-22-15 04:11AMCtrip Acquires Strategic Stake in eLong PR Newswire
May-22-15 04:00AMExpedia Announces eLong Transaction PR Newswire
May-22-15 04:00AMeLong Announces Expedia's Sale of Equity Stake PR Newswire
May-01-15 12:59PMExpedia Stock Flies Higher As Bookings Beat Views at Investor's Business Daily
May-01-15 08:06AMExpedia (EXPE) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
Apr-30-15 04:00PMeLong Reports First Quarter 2015 Unaudited Financial Results PR Newswire
1 2 3 4 5 6 ... 10 ... 13 next